A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and ...